What Happens During Targeted Therapy for CLL

Campath (alemtuzumab) is a monoclonal antibody sometimes used to treat CLL. Rituxan (rituximab) is also commonly used but is not yet approved for this disease.

You take Campath by intravenous (IV) needle either every day or many times a week. You can get this as an outpatient, meaning you don't have to stay in the hospital overnight. Each treatment lasts about two hours.

Rituximab is given by injection into a vein (IV) over a few hours, usually once every several weeks.


STAY CONNECTED

Copyright 2014 Main Line Health

Printed from: www.mainlinehealth.org/stw/Page.asp?PageID=STW016700

The information provided in this Web site is for informational purposes only. It is not a substitute for medical advice. All medical information presented should be discussed with your healthcare professional. See additional Terms of Use at www.mainlinehealth.org/terms. For more information, call 1.866.CALL.MLH.